Marché de la leucaphérèse – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00005515
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 190
Buy Now

[Rapport de recherche]Le marché de la leucaphérèse devrait atteindre 133,90 millions USD d'ici 2028, contre 74,48 millions USD en 2021 ; on estime qu'il croîtra à un TCAC de 8,7 % de 2021 à 2028.



La leucaphérèse est une procédure dans laquelle les globules blancs (leucocytes) impliqués dans la réponse immunitaire de l'organisme sont séparés d'un échantillon de sang. Il s'agit d'une forme particulière d'aphérèse dans laquelle un élément du sang, tel que des globules rouges ou des plaquettes, est obtenu tandis que le sang restant est remis en circulation. La leucaphérèse est souvent utilisée pour réduire le nombre très élevé de globules blancs (WBC), tels que les cancers du sang chroniques comme la leucémie lymphoïde chronique (LLC). Il peut également être complété pour obtenir des globules blancs pour une greffe ultérieure, par exemple pour gérer les baisses abruptes du nombre de globules blancs tout au long de la chimiothérapie anticancéreuse. Une autre utilisation est en tant que section d'une nouvelle forme d'immunothérapie, appelée thérapie par lymphocytes T à récepteur d'antigène chimérique (CAR), pour aider à combattre la leucémie, le cancer de la prostate et d'autres formes de cancers. La leucaphérèse peut être réalisée sur le demandeur du traitement (aphérèse autologue) ou sur un donneur pour une greffe ultérieure (aphérèse allogénique). Actuellement, la leucaphérèse est couramment utilisée pour traiter diverses maladies, et elle est également utilisée à des fins de diagnostic car elle peut augmenter le rendement des cellules tumorales en circulation. Des facteurs tels que le nombre croissant de donneurs de sang volontaires, l'incidence croissante des maladies hématologiques et l'augmentation de la population âgée alimentent la croissance du marché de la leucaphérèse. Cependant, le coût élevé de la leucaphérèse entrave dans une certaine mesure la croissance du marché.



Régions lucratives pour le marché de la leucaphérèse

Aperçu du marché



La transfusion sanguine est un partie intégrante de l'infrastructure et des politiques nationales de santé de divers pays. Les progrès de l'industrie médicale ont conduit à des améliorations dans les procédures de traitement des maladies et des blessures graves, ce qui a finalement propulsé le besoin de transfusion sanguine pour les patients’ survie. La prise de conscience croissante de l'importance de la transfusion sanguine et de la disponibilité du sang dans les services de santé a entraîné une augmentation du nombre de personnes disposées à donner leur sang pour des raisons médicales. Selon les données de l'Organisation mondiale de la santé (OMS), environ 117,4 millions de dons de sang ont été signalés dans le monde en 2018. Les donneurs de sang sont généralement classés comme volontaires non rémunérés, rémunérés et familiaux/de remplacement, et selon les allégations de l'OMS, les donneurs volontaires/non rémunérés constituent la principale source d'approvisionnement fiable et adéquat en sang. Selon les données de l'OMS en 2019, les dons de sang par des donneurs volontaires non rémunérés ont augmenté de 11,6 millions de 2008 à 2015 dans 139 pays du monde. La tendance au don de sang gagne également en importance dans les pays à revenu faible et intermédiaire. Selon les données présentées lors de la réunion annuelle de l'ACG en 2017, environ 13 000 procédures ont été réalisées sur 1 087 patients en 2016. La plus forte augmentation du nombre de donneurs de sang volontaires a été observée dans les pays d'Asie du Sud-Est (83 %) et les Amériques (70 %) .



Des programmes nationaux développés et déployés dans de nombreux pays attirent en outre un grand nombre de donneurs de plaquettes et de sang. Par exemple, en Inde, le National Blood Transfusion Council (NBTC), constitué au sein de l'Organisation nationale de lutte contre le sida (NACO), est l'organe central de coordination avec les State Blood Transfusion Councils (SBTC), établis au sein des State AIDS Control Societies (SACS ). Le CNTS soutient des programmes de santé pour diverses activités liées aux services de transfusion sanguine (STS). Ainsi, le nombre croissant de donneurs éligibles dans différents pays du monde renforce le besoin d'équipements de leucaphérèse utilisés pour séparer les composants sanguins requis.



Informations basées sur le type de produit



En fonction du type de produit, le marché de la leucaphérèse est divisé en dispositifs de leucaphérèse et en produits jetables pour leucaphérèse. En 2021, le segment des produits jetables pour leucaphérèse détenait une plus grande part de marché. Cependant, le segment des dispositifs de leucaphérèse devrait enregistrer un TCAC plus élevé de 2021 à 2028.



Marché de la leucaphérèse, par type de produit - 2021 et 2028

Application-Based Insights



Le marché de la leucaphérèse, par application, est divisé en applications de recherche et applications thérapeutiques. En 2021, le segment des applications de recherche détenait une plus grande part du marché et le même segment devrait enregistrer un TCAC plus élevé au cours des prochaines années.



Insights basés sur l'utilisateur final



Le marché de la leucaphérèse, par utilisateur final, est segmenté en sociétés pharmaceutiques et biotechnologiques, instituts universitaires et de recherche, fournisseurs de composants sanguins et centres de transfusion, et hôpitaux et centres de transfusion. En 2021, le segment des fournisseurs de composants sanguins et des centres de transfusion détenait la plus grande part du marché. D'autre part, le segment des hôpitaux et des centres de transfusion devrait enregistrer le TCAC le plus élevé au cours des prochaines années.



Aperçus stratégiques



Les entreprises opérant sur le marché de la leucaphérèse adoptent des stratégies telles que comme des lancements de produits, des fusions et acquisitions, des collaborations, des innovations de produits et des extensions de portefeuille de produits pour étendre leur empreinte dans le monde entier, conserver leur marque et répondre à la demande croissante des utilisateurs finaux.



Marché de la leucaphérèse - par type de produit< /p>

  • Dispositifs de leucaphérèse
    • Dispositifs d'aphérèse

    • Colonnes de leucaphérèse et séparateurs de cellules

    • Filtres de réduction leucocytaire


  • Disposables pour la leucaphérèse


Marché de la leucaphérèse - par application




  • Applications de recherche

  • Applications thérapeutiques

  • Marché de la leucaphérèse - par utilisateur final




    • Sociétés pharmaceutiques et biotechnologiques

    • Instituts universitaires et de recherche

    • Fournisseurs de composants sanguins et centres de transfusion< /li>
    • Hôpitaux et centres de transfusion


    Marché de la leucaphérèse - par géographie




    • Amérique du Nord
      • États-Unis

      • < li>Canada
      • Mexique



    • Europe
      • France

      • Allemagne

      • Italie

      • Royaume-Uni

      • Espagne

      • Reste de l'Europe



    • Asie-Pacifique (APAC)
        < li>Chine
      • Inde

      • Corée du Sud

      • Japon

      • Australie

      • Reste de l'Asie-Pacifique


    • Moyen-Orient et Afrique (MEA)
      • Afrique du Sud

      • Arabie saoudite

      • EAU

      • Reste du Moyen-Orient et Afrique



    • Amérique du Sud (SAM)
      • Brésil

      • Argentine

      • Reste of South and Central America




    Profils des entreprises




    • Asahi Kasei Corporation

    • Fresenius SE & Co KGaA

    • Haemonetics Corporation

    • Terumo Corporation

    • STEMCELL Technologies Inc.

    • HemaCare

    • Macopharma
    • AllCells

    • STEMEXPRESS

    • BioIVT


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are leukapheresis?

Leukapheresis is a procedure that has white blood cells (leukocytes) involved in the body's immune response are segregated from a blood sample. It is a particular form of apheresis in which an element of blood, such as red blood cells or platelets, is obtained while the remaining blood is restored to circulation. Leukapheresis is often used to reduce very high white blood cell (WBC) counts, such as chronic blood cancers like chronic lymphocytic leukemia (CLL). It can also be completed to obtain white blood cells for later transplant, such as to manage abrupt declines in WBC counts throughout cancer chemotherapy. Another use is as a section of a novel form of immunotherapy, termed chimeric antigen receptor (CAR) T-cell therapy, to help fight leukemia, prostate cancer, and other forms of cancers. Leukapheresis can be completed on the person claiming treatment (autologous apheresis) or on a donor for a later transplant (allogeneic apheresis). Currently, leukapheresis is commonly used to treat various diseases, and it is also used for diagnostic purposes as it can increase circulating tumor cells yields.

What are the driving factors for the leukapheresis market across the globe?

Key factors that are driving the growth of this market are number of voluntary blood donors, increasing incidence of hematologic diseases, surge in elderly population and growing demand for leukopaks in clinical research activities boost the market growth over the years.

Which product type led the leukapheresis market?

The leukapheresis disposables segment dominated the global leukapheresis market and held the largest revenue share of 61.43% in 2021.

Which end-user held the largest share in the leukapheresis market?

The blood component providers and blood centers segment dominated the global leukapheresis market and accounted for the largest revenue share of 35.03% in 2021.

Who are the key players in the leukapheresis market?

The leukapheresis market majorly consists of the players such Asahi Kasei Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation Terumo Corporation, STEMCELL Technologies Inc., HemaCare, Macopharma, AllCells, STEMEXPRESS, and BioIVT amongst others.

What is the regional market scenario of leukapheresis?

Global leukapheresis market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for leukapheresis. The growth of the region is attributed to increasing product launches coupled with increasing patient population.
The Asia Pacific region is expected to account for the fastest growth in the leukapheresis market. Increase in government investments and a number of private biotechnology companies in this region contribute to this dominant share. The rising geriatric population and increasing investment in research are said to be responsible for this growth.

The List of Companies - Leukapheresis Market

  1. Asahi Kasei Corporation
  2. Fresenius SE & Co. KGaA
  3. Haemonetics Corporation
  4. Terumo Corporation
  5. STEMCELL Technologies Inc.
  6. HemaCare
  7. Macopharma
  8. AllCells
  9. STEMEXPRESS
  10. BioIVT

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports